Kraton — Q3 2020 Earnings Presentation
20 slides from Kraton's earnings presentation, Oct 29, 2020
Slide 1: Kraton Corporation Third Quarter 2020 Earnings Presentation
Kraton Corporation Third Quarter 2020 Earnings Presentation October 29, 2020
Slide 2: Disclaimers: Cautionary Statement Regarding Forward-Looking Information
Disclaimers CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION Some of the written and oral statements and information in this presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often char
Slide 3: Disclaimers: GAAP Disclaimer
Disclaimers GAAP Disclaimer This presentation includes the use of both GAAP and non-GAAP financial measures. The non-GAAP financial measures are defined below. Tables included in this earnings release reconcile each of these non-GAAP financial measures with the most directly comparable U.S. GAAP fin
Slide 4: Current Environment - Overview
Current Environment - Overview Operations & Plants operating Planned maintenance underway as anticipated Supply Chain as planned Employee safety remains a priority China and broader Asia strong Demand & Demand trends Sequential improvement in North America Markets improving Solid demand in paving an
Slide 5: Third Quarter 2020 Financial Highlights
Third Quarter 2020 Financial Highlights ▪ Consolidated net loss of $402.6 million (Goodwill impairment of $400.0 million) ▪ Polymer segment operating loss of $5.1 million GAAP Results ▪ Chemical segment operating loss of $401.7 million ▪ Consolidated debt of $945.5 million at 9/30/2020 vs. $1,390.7
Slide 6: Polymer Segment - Q3 2020 and YTD Results
Polymer Segment - Q3 2020 and YTD Results Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 Change 2020 2019 Change ($ In millions) Volume (kT) 75.3 75.8 (0.5) 221.6 229.8 (8.2) Revenue $ 198.5 $ 261.6 $ (63.1) $ 642.8 $ 820.5 $ (177.7) Operating income $ (5.1) $ 18.3 $ (23.
Slide 7: Chemical Segment - Q3 2020 and YTD Results
Chemical Segment - Q3 2020 and YTD Results Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 Change 2020 2019 Change ($ In millions) Volume (kT) 110.5 93.1 17.4 307.8 300.6 7.2 Revenue $ 174.9 $ 182.6 $ (7.7) $ 513.6 $ 575.4 $ (61.8) Operating income (loss)(1) $ (401.7) $ 19
Slide 8: Q3 2020 and YTD Consolidated Results
Q3 2020 and YTD Consolidated Results Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 Change 2020 2019 Change ($ In millions, except per share amounts) Revenue $ 373.4 $ 444.2 $ (70.8) $ 1,156.4 $ 1,395.9 $ (239.5) Consolidated net income (loss) $ (402.6) $ 20.9 $ (423.5) $
Slide 9: Balance Sheet and Liquidity
Balance Sheet and Liquidity December 31, June 30, September 30, QTD YTD (In millions) 2019 2020 2020 Change Change Maturity ABL Facility $ — $ 15.0 $ — $ (15.0) $ — Jan-2023 USD Tranche 290.0 — — — (290.0) Mar-2025 Euro Tranche 277.1 190.7 117.3 (73.4) (159.8) Mar-2025 7.0% Senior Notes 394.8 394.8
Slide 10: Business Outlook by Geography and End Use Application
Business Outlook by Geography and End Use Application Well Diversified Portfolio Geographic Diversification Key End Uses Region % Rev Outlook Americas 47% Improving Europe 36% Stable China/Asia 17% Improving *Analysis based on Q3 TTM revenues. Excludes Cariflex divested March 6, 2020 Kraton Third Qu
Slide 11: Appendix
Appendix
Slide 12: Polymer – Revenue by Geography and End Use
Polymer – Revenue by Geography and End Use TTM September 30, 2020 Segment Revenue by Geography Segment Revenue by End Use Other Medical Roofing 12% 14% Industrial Asia Pacific 9% 8% 26% Americas 43% Adhsv & Coatings Paving 8% 20% EMEA Consumer 31% 7% Polymod Personal Care 4% 11% Lubricant Additives
Slide 13: Polymer – Revenue by Geography and Product Group
Polymer – Revenue by Geography and Product Group TTM September 30, 2020 CARIFLEX/IRSA(1) SPECIALTY POLYMERS PERFORMANCE PRODUCTS EMEA Asia Pacific 8% 9% Americas 2% Asia Pacific 33% Americas 44% Americas 50% EMEA 41% Asia Pacific 90% EMEA 23% Revenue by Geography Other Industrial 5% Consumer 8% Indu
Slide 14: Chemical – Revenue by Geography and Product Group
Chemical – Revenue by Geography and Product Group TTM September 30, 2020 ADHESIVES PERFORMANCE CHEMICALS TIRES 37% of TTM Revenue 57% of TTM Revenue 6% of TTM Revenue Americas Asia Pacific Asia Pacific 13% 12% 13% Asia Pacific Americas 35% Americas 44% EMEA 54% EMEA 34% EMEA 43% 52% Chemical Segment
Slide 15: Polymer Segment Reconciliation of Gross Profit to Adjusted Gross Profit
Polymer Segment Reconciliation of Gross Profit to Adjusted Gross Profit Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands) Gross profit $ 34,996 $ 58,478 $ 161,572 $ 191,230 Add (deduct): Transaction, acquisition related costs, restructuring, and othe
Slide 16: Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures
Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures Three Months Ended September 30, 2020 Three Months Ended September 30, 2019 Polymer Chemical Total Polymer Chemical Total (In thousands) Net income (loss) attributable to Kraton $ (403,794) $ 18,693 Net income attributab
Slide 17: Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures
Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures (a) Included in EBITDA is a $14.3 million gain on insurance for the three months ended September 30, 2019, a reimbursement for a portion of the direct costs we have incurred to date related to Hurricane Michael. Also inc
Slide 18: Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures
Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures Nine Months Ended September 30, 2020 Nine Months Ended September 30, 2019 Polymer Chemical Total Polymer Chemical Total (In thousands) Net income (loss) attributable to Kraton $ (203,676) $ 72,569 Net income attributable
Slide 19: Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures
Reconciliation of Net Income to Operating Income to Non-GAAP Financial Measures (a) Included in EBITDA is a $32.9 million gain on insurance for the nine months ended September 30, 2019, fully offsetting the lost margin in the first quarter of 2019, and reimbursement for a portion of the direct costs
Slide 20: Reconciliation of Diluted EPS to Adjusted Diluted EPS
Reconciliation of Diluted EPS to Adjusted Diluted EPS Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Diluted Earnings (Loss) Per Share $ (12.67) $ 0.58 $ (6.40) $ 2.26 Transaction, acquisition related costs, restructuring, and other costs (a) 0.03 0.04 0.34 0.13